论文信息 - Final clinical, pharmacokinetic and pharmacodynamic results of the phase I study of the novel poly(ADP-ribose)polymerase (PARP) inhibitor, AG014699, in combination with temozolomide - 字舞流文

Final clinical, pharmacokinetic and pharmacodynamic results of the phase I study of the novel poly(ADP-ribose)polymerase (PARP) inhibitor, AG014699, in combination with temozolomide

A. Harris | A. Boddy | N. Curtin | R. Plummer | M. Middleton | H. Calvert | R. Kaufman | A. Olson | P. Johnston | L. Robson | R. Wilson | R. Dewji | H. Newell | J. Evans | C. Jones